Hongwei Xu
National Yang Ming Chiao Tung University(TW)China Aerospace Science and Technology Corporation(CN)Shanghai University of Traditional Chinese Medicine(CN)Shaoxing Second Hospital(CN)Shandong Provincial Hospital(CN)Traditional Chinese Medicine Hospital of Kunshan(CN)Cancer Research Center(US)Winthrop Rockefeller Foundation(US)Shandong First Medical University(CN)Shaanxi University of Science and Technology(CN)University of Arkansas for Medical Sciences(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Peptidase Inhibition and Analysis, Cancer Mechanisms and Therapy
Most-Cited Works
- → A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1(2006)909 cited
- → NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers(2013)296 cited
- → NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase(2017)147 cited
- → Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance(2010)113 cited
- → Decreased Ferroportin Promotes Myeloma Cell Growth and Osteoclast Differentiation(2015)106 cited
- → The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells(2007)90 cited